{"id":"https://genegraph.clinicalgenome.org/r/088b0802-49b6-4c2e-ab31-df4890e7da75v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between the MCOLN1 gene and mucolipidosis type IV (ML4), an autosomal recessive lysosomal storage disorder, was evaluated using the ClinGen Clinical Validity Framework as of September 10, 2022. MCOLN1 encodes mucolipin-1, a cation channel that is involved in lysosomal exocytosis, a calcium-dependent process where endosomes fuse with lysosomes, and then fuse with the plasma membrane, via mediating intracellular calcium concentrations through its role as a calcium channel (PMID: 15336987). \nAmong patients with ML4, impaired mucolipin-1 function results in impaired lysosomal exocytosis (PMID: 16914343), leading to disease manifestations which include neurodegeneration with psychomotor retardation, ophthalmologic anomalies, and achlorhydria (as reviewed in PMID: 32604955, PMID: 21763169, PMID: 12182165). \n\nThe disease mechanism of ML4 is loss of function. ML4 was first reported by Berman et al. in 1974 (PMID: 4365943) and the first report of biallelic variants in MCOLN1 among ML4 patients was by Bargal et al. in 2000 (PMID: 10973263). Both case-level (genetic) and experimental evidence support the relationship between MCOLN1 and ML4. Reported causal variants include missense, nonsense, frameshift, and splice-altering variants (PMID: 10973263, PMID: 11030752, PMID: 15523648, PMID: 31899079, PMID: 18326692). In total, eleven variants from six probands in five publications were curated. Although there is additional published case-level evidence available, the maximum score for genetic evidence (12 points) has already been reached. \n\nExperimental evidence for the relationship between MCOLN1 and ML4 includes: the biochemical function of the gene product (mucolipin-1) being consistent with the clinical and biochemical findings identified in individuals with ML4 (PMID: 15336987, PMID: 16914343, PMID: 32604955, PMID: 21763169, PMID: 12182165); the biochemical and clinical features of MCOLN1 knockout mice (PMID: 17924347); and rescue of neurologic impairment and neuronal accumulation of undegraded lysosomal substrates via adenovirus -mediated gene therapy in MCOLN1 knockout mice (PMID: 29788236). Additional experimental evidence is available, but the maximum score for experimental evidence (6 points) has already been reached.\n\nIn sum, MCOLN1 is definitively associated with ML4. The association has been repeatedly demonstrated in both clinical and research settings, and has been upheld over time. This clinical validity classification was approved by the ClinGen Lysosomal Diseases GCEP on September 14, 2022 (SOP v9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/088b0802-49b6-4c2e-ab31-df4890e7da75","GCISnapshot":"https://genegraph.clinicalgenome.org/r/baf3301d-214e-46b5-8053-5217b52fe6c2","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/baf3301d-214e-46b5-8053-5217b52fe6c2_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-09-29T14:35:47.890Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/baf3301d-214e-46b5-8053-5217b52fe6c2_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10110","date":"2022-09-14T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/baf3301d-214e-46b5-8053-5217b52fe6c2_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/12ef79a8-1b2c-4445-b32b-8028f65917cc_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ecff3ee8-c826-445c-b59a-1aa55bcf30eb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ecff3ee8-c826-445c-b59a-1aa55bcf30eb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"shown via in vitro experiments in liposomes to result in an ion channel with reduced conductance versus wild-type (PMID: 18326692)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ecff3ee8-c826-445c-b59a-1aa55bcf30eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18326692","allele":{"id":"https://genegraph.clinicalgenome.org/r/9f5fc5d7-0ec5-45ef-8e0c-3813f2b904d4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.1615del (p.Ala539ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347341"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5bcdae65-3dda-4a4f-9950-8121ffab2d3f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bcdae65-3dda-4a4f-9950-8121ffab2d3f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18326692","allele":{"id":"https://genegraph.clinicalgenome.org/r/5c4e87ee-916c-422f-a141-104fbbeb35e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.920del (p.Leu307ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347434"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/12ef79a8-1b2c-4445-b32b-8028f65917cc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18326692","rdfs:label":"Patient 1-Goldin 2008","allele":[{"id":"https://genegraph.clinicalgenome.org/r/9f5fc5d7-0ec5-45ef-8e0c-3813f2b904d4"},{"id":"https://genegraph.clinicalgenome.org/r/5c4e87ee-916c-422f-a141-104fbbeb35e8"}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/ecff3ee8-c826-445c-b59a-1aa55bcf30eb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5bcdae65-3dda-4a4f-9950-8121ffab2d3f_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/369a573d-829c-4412-9ddb-448cb0b6030f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87b42b7c-594c-4449-bad0-255820491b72","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87b42b7c-594c-4449-bad0-255820491b72_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 18794901: in HEK293T cells, resulted in impaired cation channel activity; PMID: 25119295 - in HEK293T cells, showed altered cellular localization (retention at the endoplasmic reticulum)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/87b42b7c-594c-4449-bad0-255820491b72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15523648","allele":{"id":"https://genegraph.clinicalgenome.org/r/cbf535c8-cdfb-456e-8028-28b4767ad0e5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.1207C>T (p.Arg403Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340347"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8510bb29-7dfb-4e0a-9f9b-5b788e9a8be9","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8510bb29-7dfb-4e0a-9f9b-5b788e9a8be9_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 15523648: shown via RT-PCR to alter splicing and lead to premature truncation and nonsense-mediated decay","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/8510bb29-7dfb-4e0a-9f9b-5b788e9a8be9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15523648","allele":{"id":"https://genegraph.clinicalgenome.org/r/0bcdd058-53b4-4592-99bf-5ef348a3d362","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3:c.236_237ins[NC_012920.1:g.12435_12528]","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/5138"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/369a573d-829c-4412-9ddb-448cb0b6030f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15523648","rdfs:label":"Patient 1-Goldin","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0bcdd058-53b4-4592-99bf-5ef348a3d362"},{"id":"https://genegraph.clinicalgenome.org/r/cbf535c8-cdfb-456e-8028-28b4767ad0e5"}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/87b42b7c-594c-4449-bad0-255820491b72_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8510bb29-7dfb-4e0a-9f9b-5b788e9a8be9_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/d9bba310-2cd2-4de3-99a3-2bacf008ab0e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/158b3965-e8ae-4dd0-b005-9b622cb8942a","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/158b3965-e8ae-4dd0-b005-9b622cb8942a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11030752","allele":{"id":"https://genegraph.clinicalgenome.org/r/51547622-2af3-4985-8bc7-6076bedef9cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.304C>T (p.Arg102Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340345"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/888f3ad3-cd48-4b25-8dad-0a4744397c93","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/888f3ad3-cd48-4b25-8dad-0a4744397c93_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 18794901: shown to impair ion channel activity in HEK293T cells; PMID: 22268962: in HeLa cells, shown to result in retention of the protein in the endoplasmic reticulum (versus localizing to lysosomes, as seen for the wild-type protein)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/888f3ad3-cd48-4b25-8dad-0a4744397c93_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11030752","allele":{"id":"https://genegraph.clinicalgenome.org/r/d970a96a-6262-4ba4-a745-6b85a57c5845","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.1084G>T (p.Asp362Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340344"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d9bba310-2cd2-4de3-99a3-2bacf008ab0e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11030752","rdfs:label":"Patient 42","allele":[{"id":"https://genegraph.clinicalgenome.org/r/51547622-2af3-4985-8bc7-6076bedef9cf"},{"id":"https://genegraph.clinicalgenome.org/r/d970a96a-6262-4ba4-a745-6b85a57c5845"}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/158b3965-e8ae-4dd0-b005-9b622cb8942a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/888f3ad3-cd48-4b25-8dad-0a4744397c93_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.0},{"id":"https://genegraph.clinicalgenome.org/r/5aaa09bc-ee17-4dda-95b3-7592c48cc6a7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/916c8b63-91ca-4303-ae0d-599fec2f3496","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/916c8b63-91ca-4303-ae0d-599fec2f3496_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"PMID: 10973263: shown via RT-PCR to result in skipping of exon 4, frameshift, and premature truncation after the first 21 amino acids of the protein","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/916c8b63-91ca-4303-ae0d-599fec2f3496_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10973263","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd6450d3-7563-49ce-8fc8-0832a741780b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.406-2A>G (p.=)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA284833"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/05383f88-2540-4e4f-ab90-49e397c433a3","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/05383f88-2540-4e4f-ab90-49e397c433a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10973263","allele":{"id":"https://genegraph.clinicalgenome.org/r/a4415ebe-348e-46da-8005-45ccb51aea0d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.2(MCOLN1):c.-1015_789del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA253418"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5aaa09bc-ee17-4dda-95b3-7592c48cc6a7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10973263","rdfs:label":"Patient 5","allele":[{"id":"https://genegraph.clinicalgenome.org/r/a4415ebe-348e-46da-8005-45ccb51aea0d"},{"id":"https://genegraph.clinicalgenome.org/r/cd6450d3-7563-49ce-8fc8-0832a741780b"}],"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/05383f88-2540-4e4f-ab90-49e397c433a3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/916c8b63-91ca-4303-ae0d-599fec2f3496_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/43499fd8-a8b8-49d6-8ccc-57e77df97ac6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55256572-0bd7-475d-b6c6-d6745eb8bb3a","type":"EvidenceLine","dc:description":"Scored 0.75pts per variant to yield 1.5pts total and prevent double-counting for homozygous variant. ","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/55256572-0bd7-475d-b6c6-d6745eb8bb3a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10973263","allele":{"id":"https://genegraph.clinicalgenome.org/r/59dd71d4-0ed1-4013-840e-841477c6682f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.964C>T (p.Arg322Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340342"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/43499fd8-a8b8-49d6-8ccc-57e77df97ac6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10973263","rdfs:label":"Patient 1 Arab-Druze-Bargal","allele":{"id":"https://genegraph.clinicalgenome.org/r/59dd71d4-0ed1-4013-840e-841477c6682f"},"firstTestingMethod":"PCR","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/55256572-0bd7-475d-b6c6-d6745eb8bb3a_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/90df7184-8ee7-44c9-afca-4e4a79e2fd50_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8ecfd60-8ac5-4ff2-9170-0b32de558941","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e8ecfd60-8ac5-4ff2-9170-0b32de558941_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31899079","allele":{"id":"https://genegraph.clinicalgenome.org/r/c7e0ff1d-d9a1-444f-933a-bee16cbb9866","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.1503dup (p.Ile502HisfsTer106)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320601"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8a773a3a-061c-4ed8-b45f-af6e90eba3b7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a773a3a-061c-4ed8-b45f-af6e90eba3b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31899079","allele":{"id":"https://genegraph.clinicalgenome.org/r/fd91b678-f010-44bd-977f-e719cef83464","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_020533.3(MCOLN1):c.937_939del (p.Phe313del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320602"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/90df7184-8ee7-44c9-afca-4e4a79e2fd50","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31899079","rdfs:label":"Patient 1-Yamaguchi","allele":[{"id":"https://genegraph.clinicalgenome.org/r/c7e0ff1d-d9a1-444f-933a-bee16cbb9866"},{"id":"https://genegraph.clinicalgenome.org/r/fd91b678-f010-44bd-977f-e719cef83464"}],"detectionMethod":"Variants identified via exome sequencing and confirmed by Sanger sequencing","firstTestingMethod":"Exome sequencing","previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e8ecfd60-8ac5-4ff2-9170-0b32de558941_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8a773a3a-061c-4ed8-b45f-af6e90eba3b7_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/baf3301d-214e-46b5-8053-5217b52fe6c2_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/baf3301d-214e-46b5-8053-5217b52fe6c2_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a160b2e5-634e-43ff-9501-781b2b245f41","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0690e4c4-f721-41b1-83ff-e9ed80d7d45d","type":"Finding","dc:description":"MCOLN1 knockout mice show progressive neurologic impairment, with gait deficits followed by hind-limb paralysis and premature death, dense inclusion bodies in neurons (reflecting accumulation of undegraded substrates in lysosomes), elevated plasma gastrin, and retinal degeneration, recapitulating key features of the human mucolipidosis IV disease phenotype ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17924347","rdfs:label":"MCOLN1 knockout mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/372a26e7-1e3d-4c5a-9895-ac01e516da6d","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71c4196b-3414-4ebf-a735-d10caf650025","type":"Finding","dc:description":"Gene therapy-treated MCOLN1 knockout mice show restored motor function, improved neuronal myelination, and decreased neuronal accumulation of undegraded lysosomal substrates ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33822942","rdfs:label":"Gene therapy in MCOLN1 knockout mouse","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/baf3301d-214e-46b5-8053-5217b52fe6c2_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8dacd8dd-3aaf-46f2-90e8-852f3ad88de4","type":"EvidenceLine","dc:description":"Per ClinGen LD GCEP guidelines, gene products that have a well-established function in a metabolic pathway are scored 2 points","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52224e75-2f2c-48fa-b3bf-333ffc889f64","type":"Finding","dc:description":"MCOLN1 encodes mucolipin-1, a cation channel that is involved in lysosomal exocytosis, a calcium-dependent process where endosomes fuse with lysosomes, and then fuse with the plasma membrane, via mediating intracellular calcium concentrations through its role as a calcium channel (PMID: 15336987). Patients with mucolipidosis IV (ML4) show impaired mucolipin-1 cation channel activity and lysosomal exocytosis (PMID: 16914343), which was demonstrated via assessing lysosomal exocytosis in human fibroblasts via measuring production of a fluorescent cleavage product of a soluble lysosomal enzyme, NAG; ML4 patient fibroblasts showed 250% less NAG release versus control fibroblasts and show no mucolipin-1 cation channel activity. In addition, transfection of ML4 patient fibroblasts with wild-type MCOLN1 cDNA resulted in coincident restored mucolipin-1 cation channel activity and restored lysosomal exocytosis. Thus, the impaired lysosomal exocytosis due to deficient mucolipin-1 cation channel activity seen in ML4 patients is consistent with the function of mucolipin-1, the protein encoded by MCOLN1, as a cation channel involved in lysosomal exocytosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16914343","rdfs:label":"Impaired mucolipin-1 activity and exocytosis in ML4 patients","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":5105,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/13LvpypnrvM","type":"GeneValidityProposition","disease":"obo:MONDO_0009653","gene":"hgnc:13356","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_baf3301d-214e-46b5-8053-5217b52fe6c2-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}